Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)

Home / Key Publications / Oncology Biomarker Testing: A Resource Hub for HCPs / Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)

You May Also Like

Professor Man-Fung Yuen

Expert Opinions: Thought Leadership for Healthcare Professionals

7 October 2026

HBV Diagnostic Strategies in the Era of Novel Therapies

Expert Opinions: Thought Leadership for Healthcare Professionals

7 October 2026

Use of Procalcitonin in LRTI and Sepsis Management

Expert Opinions: Thought Leadership for Healthcare Professionals

11 May 2026

The Role of Anti-Müllerian Hormone (AMH) in Polycystic Ovarian Syndrome (PCOS) Diagnosis: Providing a Simplified, Accessible, and Objective Test to Improve Patient Outcomes

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.